Australia, Nov. 12 -- Definium Therapeutics US Inc., owns the trademark (2661528) for 'NUEVDI' till April 17, 2036.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations for the treatment of mental health conditions; pharmaceutical preparations, namely, psychotropic, psychoactive, and psychedelic medicinal preparations for the treatment of mental health conditions; pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely, generalized anxiety disorder (gad) and major depressive disorder (mdd).]
Type of Mark: Word
Date of Acceptance: June 25
Registration Advertised: Nov. 11
For further details contact John Paul Oleksiuk Cooley LLP .
The original document can be viewed at: https...